Halozyme Therapeutics (HALO) traded up 0.88 % during a 24 hours period ending at 07:04 AM Central Europe on Friday 30th. One Halozyme Therapeutics stock can currently be bought for about USD 131.18 on popular exchanges. Current supply of Halozyme Therapeutics stocks is 113.5 mn. Halozyme Therapeutics has a current market capitalization of USD 14.8 bn and approximately USD 245.9 mn worth of Halozyme Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Halozyme Therapeutics has traded 18.82 % up. Simple moving average of last 200 days is at USD 83.08. The highest price of past 52 weeks was recorded at USD 132.55 on 10/29/2026. 52 weeks low was at USD 61.23 on 12/11/2025.

Here is how related stocks have performed in the past 24 hours:

  • Curtiss-wright (CW) traded up 4.03 % and now trades at USD 496.74. Curtiss-wright has a market capitalisation of USD 17.6 bn. Current price/earnings ratio for Curtiss-wright is 32.86.

  • Ftai Aviation (FTAI) traded up 5.34 % and now trades at USD 196.01. Current market capitalisation for Ftai Aviation is USD 17.2 bn. Current price/earnings ratio for Ftai Aviation is 36.38.

  • Tpg Inc (TPG) traded up 0.02 % and now trades at USD 47.94. Tpg Inc has a market capitalisation of USD 17.2 bn. Tpg Inc has a current price to earnings ratio of 53.34.

  • General Mills (GIS) traded up 0.82 % and now trades at USD 33.32. Current market capitalisation for General Mills is USD 17.7 bn.

  • Idex (IEX) traded up 0.33 % and now trades at USD 239.33. Idex has a market capitalisation of USD 17.6 bn. Current price/earnings ratio for Idex is 33.11.

About Halozyme Therapeutics

Halozyme Therapeutics, Inc. is a biopharmaceutical company engaged in developing products for the diabetes, cancer, dermatology, and drug delivery markets. Its platform technology revolves around recombinant human hyaluronidase along with additional enzymes, which the company applies to its proprietary programs and partnerships with pharmaceutical companies. You can find more information about this company and its offerings on its website, located at www.halozyme.com . Halozyme Therapeutics Inc. is Nasdaq-traded.